Clinical Trials List
Protocol Number113314 (FLU Q-QIV-003)
2010-10-01 - 2011-08-31
Phase III
Terminated2
-
Trial Applicant
GlaxoSmithKline
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Chun-yi Lu Division of Pediatrics
- 戴君芙 Division of Pediatrics
- 邵蓓嵐 Division of Pediatrics
- 賴貞吟 Division of Pediatrics
- Luan-Yin Chang Division of Pediatrics
- 陳文發 Division of Pediatrics
- 黃文嬋 Division of Pediatrics
- 張馨宇 Division of Pediatrics
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Hsiao-chuan Lin Division of Pediatrics
- Chang-Ching Wei Division of Pediatrics
- 翁德甫 Division of Pediatrics
- Hung-Chih Lin Division of Pediatrics
- Bai-Horng Su Division of Pediatrics
- 謝欣洋 Division of Pediatrics
- Yi-Chin Peng Division of Pediatrics
- Shu-Fen Wu Division of Pediatrics
- An-Chyi Chen Division of Pediatrics
- Sheng-Shing Lin Division of Pediatrics
- Hsiang-Yu Lin Division of Pediatrics
- I-Ching Chou Division of Pediatrics
- Hsiao-Yu Chiu Division of Pediatrics
- 謝宗學 Division of Pediatrics
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
250 participants
-
Global
2700 participants
